Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 05, 2020
CURE Pharmaceutical has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s pharmaceutical groups specialized in medicinal cannabis products.
read more
Friday, February 05, 2021
CureVac and Rentschler Biopharma announced the companies have initiated the set-up of manufacturing capabilities for CureVac´s COVID-19 vaccine, CVnCoV.
read more
CureVac AG has confirmed internal efforts are focused on the development of a coronavirus vaccine.
read more
Monday, December 02, 2019
CureVac has received manufacturing authorization for clinical trial materials produced under GMP from Regierungspräsidium Tübingen for the company’s scaled up GMP III production suite.
read more
Friday, December 04, 2020
CureVac and Wacker Chemie have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
read more
Berkeley Lights, Inc. and Curia, formerly AMRI, a contract research, development and manufacturing organization (CDMO), announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its ...
read more
Curia, a contract research, development and manufacturing organization, announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical ...
read more
Curia, formerly AMRI, announced that they will collaborate on a robust development platform for Replicate’s srRNA therapeutics. The strategic collaboration unites two RNA therapeutics industry leaders.
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
Curia made an agreement to provide Curia and its clients a means of access to Touchlight’s doggybone DNA (dbDNA).
read more
Curia Global, Inc. announced expansion plans to its Glasgow, UK facility and provided updates on the ongoing expansion in Albuquerque, NM.
read more
Curia hosted a ground-breaking ceremony to mark the beginning of construction of its expanded campus in Albuquerque, New Mexico.
read more
Curia Global announced the completion of a $4M investment to upgrade its two API aseptic suites in Valladolid, Spain.
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, agreed to acquire Integrity Bio Inc, a privately held formulation and fill-finish organization headquartered in Camarillo, California.
read more
Curia, formerly AMRI, agreed to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research, development and manufacturing organization with facilities in California, Massachusetts, and Texas. LakePharma uses technology ...
read more